World Journal of Clinical Oncology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Ni CX, Xu JJ, Pang Y, Xu JJ. Treatment strategies targeting the phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin pathway against triple-negative breast cancer. World J Clin Oncol 2025; 16(5): 104623 [PMID: 40503407 DOI: 10.5306/wjco.v16.i5.104623]
URL:	https://www.wjgnet.com/2218-4333/full/v16/i5/104623.htm

Number	Citing Articles
1	Ting Yang, Yiming Lu, Pengfei Yu, Jiahui Chen, Xiangdong Cheng. Remodeling the immune microenvironment: Engineering IL-2 variants to overcome clinical bottlenecks in PD-1 inhibitor plus chemotherapy. Critical Reviews in Oncology/Hematology 2026; 226 doi: 10.1016/j.critrevonc.2026.105469
2	Sunil V Jagtap, Shubham S Jagtap. Prognostic significance of stem cell markers: In triple-negative breast cancers. World Journal of Clinical Oncology 2026; 17(7): 119673 doi: 10.5306/wjco.v17.i7.119673 Abstract(9) \| Core Tip(8) \| Full Article(HTML)(63) \| Full Article (PDF)-389K(38) \| Full Article with Cover (PDF)-726K(13) \| Full Article (XML)-70K(8) \| Audio-197631K(1) \| Peer-Review Report-242K(3) \| Answering Reviewers-349K(3) \| Times Cited (0) \| Total Visits (130) \| Open
3	Azza Suliman, Arij Fouzat Hassan, Sumayyah Saeed, Ala-Eddin Al Moustafa, Ashraf Khalil, Abdelbary Elhissi. Liposomal delivery of DK14 chalcone analogue: A promising therapeutic strategy against triple-negative breast cancer. Journal of Drug Delivery Science and Technology 2026; 115 doi: 10.1016/j.jddst.2025.107601